Jointown Pharmaceutical Group Co Ltd
Jointown Pharmaceutical Group Co., Ltd engages in pharmaceutical distribution and supply chain business in China and internationally. It is also involved in general agency brand promotion; pharmaceutical industrial self-production and OEM; and pharmaceutical new retail and ten-thousand store alliance plan businesses. In addition, the company provides medical health and technology value-added serv… Read more
Jointown Pharmaceutical Group Co Ltd (600998) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.015x
Based on the latest financial reports, Jointown Pharmaceutical Group Co Ltd (600998) has a cash flow conversion efficiency ratio of 0.015x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥528.22 Million) by net assets (CN¥35.07 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Jointown Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Jointown Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Jointown Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jointown Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Allied Gold Corporation
NYSE:AAUC
|
0.432x |
|
Betsson AB
PINK:BTSBF
|
0.026x |
|
Boralex Inc
PINK:BRLXF
|
0.019x |
|
Sichuan Teway Food Group Co Ltd
SHG:603317
|
0.081x |
|
Safestore Holdings plc
PINK:SFSHF
|
0.026x |
|
Intershop Holding AG
SW:ISN
|
0.014x |
|
Dialog Group Bhd
KLSE:7277
|
0.026x |
|
Titan Cement International S.A.
PINK:TTCIF
|
0.089x |
Annual Cash Flow Conversion Efficiency for Jointown Pharmaceutical Group Co Ltd (2007–2024)
The table below shows the annual cash flow conversion efficiency of Jointown Pharmaceutical Group Co Ltd from 2007 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥33.59 Billion | CN¥3.08 Billion | 0.092x | -43.44% |
| 2023-12-31 | CN¥29.48 Billion | CN¥4.78 Billion | 0.162x | +16.75% |
| 2022-12-31 | CN¥28.69 Billion | CN¥3.99 Billion | 0.139x | +8.76% |
| 2021-12-31 | CN¥27.07 Billion | CN¥3.46 Billion | 0.128x | -4.96% |
| 2020-12-31 | CN¥25.62 Billion | CN¥3.44 Billion | 0.134x | +6.70% |
| 2019-12-31 | CN¥21.97 Billion | CN¥2.77 Billion | 0.126x | +110.15% |
| 2018-12-31 | CN¥20.38 Billion | CN¥1.22 Billion | 0.060x | +215.75% |
| 2017-12-31 | CN¥19.54 Billion | CN¥-1.01 Billion | -0.052x | -244.26% |
| 2016-12-31 | CN¥12.01 Billion | CN¥431.26 Million | 0.036x | -18.91% |
| 2015-12-31 | CN¥9.85 Billion | CN¥435.96 Million | 0.044x | +308.58% |
| 2014-12-31 | CN¥8.09 Billion | CN¥-171.68 Million | -0.021x | -181.86% |
| 2013-12-31 | CN¥5.34 Billion | CN¥138.47 Million | 0.026x | +133.99% |
| 2012-12-31 | CN¥4.84 Billion | CN¥-368.93 Million | -0.076x | +4.45% |
| 2011-12-31 | CN¥4.30 Billion | CN¥-343.61 Million | -0.080x | +69.06% |
| 2010-12-31 | CN¥4.00 Billion | CN¥-1.03 Billion | -0.258x | +17.27% |
| 2009-12-31 | CN¥1.67 Billion | CN¥-521.70 Million | -0.312x | -193.12% |
| 2008-12-31 | CN¥1.48 Billion | CN¥494.75 Million | 0.335x | +550.37% |
| 2007-12-31 | CN¥1.28 Billion | CN¥65.95 Million | 0.051x | -- |